Cargando…
Clinically Meaningful Use of Blood Tumor Markers in Oncology
Before the introduction of modern imaging techniques and the recent developments in molecular diagnosis, tumor markers (TMs) were among the few available diagnostic tools for the management of cancer patients. Easily obtained from serum or plasma samples, TMs are minimally invasive and convenient, a...
Autores principales: | Holdenrieder, Stefan, Pagliaro, Lance, Morgenstern, David, Dayyani, Farshid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155072/ https://www.ncbi.nlm.nih.gov/pubmed/28042579 http://dx.doi.org/10.1155/2016/9795269 |
Ejemplares similares
-
Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis
por: Holdenrieder, Stefan, et al.
Publicado: (2017) -
How to develop a meaningful radiomic signature for clinical use in oncologic patients
por: Papanikolaou, Nikolaos, et al.
Publicado: (2020) -
Making Meaningful Clinical Use of Biomarkers
por: Selleck, Matthew J, et al.
Publicado: (2017) -
鳞状上皮细胞癌抗原水平新检测方法在宫颈癌、肺癌和头颈部癌鉴别诊断中的性能及临床表现
por: HOLDENRIEDER, Stefan, et al.
Publicado: (2018) -
Thymoma calcification: Is it clinically meaningful?
por: Harris, Kassem, et al.
Publicado: (2011)